Gossamer Bio GOSS
NASDAQ GOSS
$10.71 -0.22 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Gains from Sales and Divestitures (2021 - 2024)

Updated

Gossamer Bio (GOSS) posted Gains from Sales and Divestitures of -$185,000 for Q4 2024.

Analysis

Gossamer Bio (GOSS) Gains from Sales and Divestitures (2021 - 2024) Analysis & Trends

For FY2024, Gossamer Bio's Gains from Sales and Divestitures came in at -$806,000.

  • In prior years, Gossamer Bio's Gains from Sales and Divestitures was -$726,000 in FY2023 and -$20,000 in FY2021.
  • The Q4 2024 figure stands as the highest quarterly Gains from Sales and Divestitures since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Gossamer Bio 42.84 Mn -430.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -185,000.00
Sep 30, 2024 -305,000.00
Mar 31, 2024 -316,000.00
Sep 30, 2023 -726,000.00
Dec 31, 2021 64,000.00
API Access

Gossamer Bio Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=GOSS&period=max&api_key=YOUR_API_KEY